Literature DB >> 1873712

Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer.

P K Wagner1, A Ramaswamy, J Rüschoff, P Schmitz-Moormann, M Rothmund.   

Abstract

The number of regional lymph nodes was determined in sites relevant to lymphadenectomy in gastric cancer in 30 cadavers. Tissue was cleared by dissolving fatty tissue, thus making lymph nodes with a diameter of at least 1 mm visible. All lymph node stations indicated by the Japanese Research Society for Gastric Cancer were studied. In stations 1-11 (corresponding with R2 resection) an average of 27 nodes (range 17-44 nodes) was found, whereas stations 1-16 (corresponding with R3 resection) showed an average of 43 nodes (range 25-64 nodes). These values are higher than those usually obtained from lymphadenectomy for gastric cancer. Striking individual differences in the total number of lymph nodes and the number of single stations was observed. The number of lymph nodes in these investigations are the normal anatomical values and serve as quality control of lymph node dissection in gastric carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 1873712     DOI: 10.1002/bjs.1800780719

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  32 in total

1.  Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Antonio Di Cintio; Sabrina Ghinassi; Luigi Coppola; Luigi Pinnarelli; Augusto Belardi; Maurizio Koch; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2010-10

2.  Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy.

Authors:  Guang-Tan Lin; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

3.  Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

Authors:  Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

4.  Relationship between nodal stage and the number of dissected perigastric nodes in gastric cancer.

Authors:  T Ichikura; Y Furuya; S Tomimatsu; Y Okusa; T Ogawa; K Mukoda; H Mochizuki; S Tamakuma
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  D2 lymphadenectomy (over-D1 dissection) for advanced gastric cancer is an evidence-based procedure.

Authors:  Federico Bozzetti
Journal:  J Gastrointest Surg       Date:  2011-06-30       Impact factor: 3.452

6.  Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.

Authors:  Juhan Lee; Yoo-Min Kim; Yanghee Woo; Kazutaka Obama; Sung Hoon Noh; Woo Jin Hyung
Journal:  Surg Endosc       Date:  2015-01-29       Impact factor: 4.584

Review 7.  N staging: the role of the pathologist.

Authors:  Costanza De Marco; Alberto Biondi; Riccardo Ricci
Journal:  Transl Gastroenterol Hepatol       Date:  2017-02-20

8.  Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion.

Authors:  B H Lee; S Y Chin; S A Kim; K H Kim; Y S Do
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

9.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Authors:  J R Siewert; K Böttcher; H J Stein; J D Roder
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

Review 10.  Robot-assisted gastrectomy for gastric cancer: current status and technical considerations.

Authors:  Andrea Coratti; Mario Annecchiarico; Michele Di Marino; Edoardo Gentile; Francesco Coratti; Pier Cristoforo Giulianotti
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.